A61K 47/548
Phosphates or phosphonates
Official title: {Phosphates or phosphonates, e.g. bone-seeking (phospholipids A61K47/544)}
A61K47/548 (Phosphates or phosphonates) appears on 255 US grants and 433 published applications in this corpus.
Search patents in A61K- Granted patents
- 255
- Published applications
- 433
- Assignees
- 234
- Inventors
- 920
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 2 |
| 2002 | 2 | 6 |
| 2003 | 1 | 4 |
| 2004 | 3 | 7 |
| 2005 | 2 | 13 |
| 2006 | 2 | 12 |
| 2007 | 3 | 6 |
| 2008 | 12 | 10 |
| 2009 | 2 | 10 |
| 2010 | 3 | 8 |
| 2011 | 4 | 10 |
| 2012 | 1 | 3 |
| 2013 | 6 | 8 |
| 2014 | 10 | 18 |
| 2015 | 16 | 15 |
| 2016 | 12 | 18 |
| 2017 | 13 | 22 |
| 2018 | 13 | 25 |
| 2019 | 18 | 25 |
| 2020 | 14 | 24 |
| 2021 | 13 | 24 |
| 2022 | 19 | 31 |
| 2023 | 13 | 35 |
| 2024 | 14 | 40 |
| 2025 | 14 | 28 |
| 2026 | 15 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Bisphosphonate-linked compounds15 Sep 2026US 12,734,241 B2Oregon Health & Science University
- Muscle targeting complexes and formulations for treating myotonic dystrophy4 Aug 2026US 12,697,394 B2Dyne Therapeutics, Inc.
- Lipoprotein-mimicking solid lipid nanoparticles for drug delivery and uses thereof23 Jun 2026US 12,662,673 B2Tionlab Therapeutics
- Polymeric nanocarriers and methods of use thereof9 Jun 2026US 12,648,913 B2Vanderbilt University
- Stat degraders and uses thereof8 Oct 2026US 2026/0306642 A1Recludix Pharma, Inc.
- Lipid nanoparticle compositions and uses thereof1 Oct 2026US 2026/0294935 A1Beijing Jitai Life Science Ltd
- Compositions and methods for treating tendon and bone injuries24 Sep 2026US 2026/0284201 A1The Regents of the University of California
- Enhanced inhibitors of enpp1 and uses thereof10 Sep 2026US 2026/0263604 A1Petragen, Inc.
- Compound, conjugate, composition, and uses thereof10 Sep 2026US 2026/0263605 A1Rigerna Therapeutics (Beijing) Co., Ltd.
Most cited
By later US patents
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages851US 5,185,444 AAnti-Gene Deveopment Group · 1993
- Sequence-specific binding polymers for duplex nucleic acids786US 5,166,315 AAnti-Gene Development Group · 1992
- Sequence-specific binding polymers for duplex nucleic acids493US 5,405,938 AAnti-Gene Development Group · 1995
- Morpholino-subunit combinatorial library and method422US 5,506,337 AAntivirals Inc. · 1996